Ethics Approval

The National Spanish Agency's Department of Medicines for Human Use approved the study July 16, 2020. This study was approved by the Institutional Ethics Committee, for Drug Research of the Canary Islands University Hospital Complex, October 15, 2020 (VIRTUAL Extraordinary Act 13/2020, September 2020).

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Author Declaration of Transparency

I, Alicia Rodríguez-Zurita, affirm that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned have been explained.